FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter

Posted on by admin

Approval was based on the combined results from five studies of adults with supraventricular tachycardia.

Leave a Reply

Your email address will not be published. Required fields are marked *